Skip to main content

Day: August 27, 2021

Sugarbud Announces Partnership with ROSE LifeScience and Entry into Québec

CALGARY, Alberta, Aug. 27, 2021 (GLOBE NEWSWIRE) — Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.DB, SUGR.WR, SUGR.WS, SUGR.WT) (OTCQB: SBUDF) (“Sugarbud” or the “Company“) is pleased to announce that it has entered into a Sales, Marketing, Supply and Distribution agreement (the “Agreement“) with ROSE LifeScience Inc. (“ROSE“) for the Province of Québec. Supply Agreement Under the terms of the Agreement, Sugarbud will be partnering with ROSE to bring Sugarbud grown premium craft cannabis to the province of Québec under the ROSE brand ELEKT Cannabis. The Agreement with ROSE is subject to customary regulatory and new product notification requirements. “We are thrilled to be partnering with ROSE to bring select Sugarbud grown premium craft cannabis strains to the province of Québec...

Continue reading

Quantum Genomics Presents Results from Phase IIb QUORUM Study of Firibastat in Heart Failure at the European Society of Cardiology Meeting

Firibastat is as efficient as the current standard of care (ramipril) in preventing the degradation of the left ventricular ejection fraction (primary endpoint) after myocardial infarction in full study population Firibastat demonstrated better efficacy compared to ramipril in severe patients with low ejection fraction Firibastat improved blood pressure profile in study population Good safety profile observed from two doses of firibastatPARIS, Aug. 27, 2021 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and resistant hypertension and heart failure, today announced results of the Phase IIb QUORUM study were presented by Prof. Gilles Montalescot (Paris) on...

Continue reading

Genmab to Present at Morgan Stanley 19th Annual Global Healthcare Conference

Media Release Copenhagen, Denmark, 27 August, 2021 Genmab A/S (Nasdaq: GMAB) announced today that its CEO, Jan van de Winkel, Ph.D. will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference at 8:00 AM EDT / 2:00 PM CEST on September 9, 2021. A webcast of the event, which will include brief opening remarks followed by a question-and-answer session, will be available on Genmab’s website at https://ir.genmab.com/events-and-presentations#content About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation...

Continue reading

Himax Technologies, Inc. to Attend Deutsche Bank dbAccess IAA Cars Virtual Conference 2021 on September 6 – September 7, 2021

TAINAN, Taiwan, Aug. 27, 2021 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced that the Company will attend Deutsche Bank dbAccess IAA Cars Virtual Conference 2021 on September 6 – September 7, 2021. The Company management will host meetings with interested investors during the conference dates. Conference participation is by invitation only and registration is mandatory. For more information on the conference or to schedule a one-on-one or group meeting, please contact a Deutsche Bank representative or the conference coordinator at: dbAccess.cars@db.com About Himax Technologies, Inc. Himax Technologies, Inc. (NASDAQ: HIMX) is a fabless semiconductor solution provider dedicated to display...

Continue reading

Prospect Ridge Resources Corp. Announces Property Option Agreement; $6 Million Non-Brokered Private Placement; and Appoints Former CEO and Chairman of Fortuna Silver Mines Inc. as Chief Executive Officer

VANCOUVER, British Columbia, Aug. 27, 2021 (GLOBE NEWSWIRE) — Prospect Ridge Resources Corp. (CSE:PRR) (the “Company” or “Prospect“) is pleased to announce that it has entered into a property option agreement with Loan Wolf Exploration Ltd. (“Loan Wolf”) dated August 26, 2021 (the “Agreement“), pursuant to which the Company has acquired options to purchase a 100% interest in and to certain mineral claims and placer claims collectively known as the Holy Grail Property (the “Property”). Such options are comprised of: (1) an option to purchase 50% of the mineral claims comprising the Property (the “First Option”); (2) an option to purchase the remaining 50% of the mineral claims comprising the Property (the “Second Option”); and (3) an option (the “Placer Option” and, together with the First Option...

Continue reading

On the statement of the majority shareholder of AB “Ignitis grupė”

On the statement of the majority shareholder of AB “Ignitis grupė” with a proposal to distribute dividends for the first half of 2021 AB “Ignitis grupė” (hereinafter – Ignitis Group or the Company) informs that on 27 August 2021 it received a statement from the Ministry of Finance of Republic of Lithuania, who owns 73.08% of Company’s shares, (hereinafter – the Majority Shareholder) with a proposal to distribute dividends to shareholders of the Company for the first half of 2021. The Majority Shareholder has submitted the statement in accordance with Article 601 of the Law on Companies of the Republic of Lithuania as well as the Divided Policy of the Company, which stipulates that EUR 85 million shall be distributed in dividends for the financial year of 2020, and for every consecutive year the dividends shall increase by at least 3%,...

Continue reading

On the statement of the majority shareholder of AB “Ignitis grupė” with a proposal to distribute dividends for the first half of 2021

AB “Ignitis grupė” (hereinafter – Ignitis Group or the Company) informs that on 27 August 2021 it received a statement from the Ministry of Finance of Republic of Lithuania, who owns 73.08% of Company’s shares, (hereinafter – the Majority Shareholder) with a proposal to distribute dividends to shareholders of the Company for the first half of 2021. The Majority Shareholder has submitted the statement in accordance with Article 601 of the Law on Companies of the Republic of Lithuania as well as the Divided Policy of the Company, which stipulates that EUR 85 million shall be distributed in dividends for the financial year of 2020, and for every consecutive year the dividends shall increase by at least 3%, compared to the amount paid for the previous financial year. Respectively, the amount to be paid for the first half of 2021 is equal to...

Continue reading

Unibel – Obtention de l’autorisation de la Commission européenne relative à la cession de la marque Leerdammer® et de tous ses droits attachés

Obtention de l’autorisation de la Commission européenne relative à la cession de la marque Leerdammer® et de tous ses droits attachés Suresnes, le 27 août 2021 La Commission européenne a autorisé sans réserve au titre du contrôle des concentrations le projet de cession de Leerdammer1 à Lactalis annoncé le 19 mars dernier. Cette décision constitue une nouvelle étape dans le processus de finalisation de l’opération. La réalisation définitive de l’opération devrait intervenir le 30 septembre 2021, conformément aux termes de l’accord d’échange signé le 13 juillet 2021 suite à l’obtention d’un avis favorable unanime des instances représentatives du personnel devant être consultées dans le cadre de l’opération. Le Groupe Bel tiendra le marché informé de toute évolution significative relative à l’opération ainsi qu’aux opérations d’offres publiques...

Continue reading

Bel – Obtention de l’autorisation de la Commission européenne relative à la cession de la marque Leerdammer® et de tous ses droits attachés

Obtention de l’autorisation de la Commission européenne relative à la cession de la marque Leerdammer® et de tous ses droits attachés Suresnes, le 27 août 2021 La Commission européenne a autorisé sans réserve au titre du contrôle des concentrations le projet de cession de Leerdammer1 à Lactalis annoncé le 19 mars dernier. Cette décision constitue une nouvelle étape dans le processus de finalisation de l’opération. La réalisation définitive de l’opération devrait intervenir le 30 septembre 2021, conformément aux termes de l’accord d’échange signé le 13 juillet 2021 suite à l’obtention d’un avis favorable unanime des instances représentatives du personnel devant être consultées dans le cadre de l’opération. Le Groupe Bel tiendra le marché informé de toute évolution significative relative à l’opération ainsi qu’aux opérations d’offres publiques...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.